Press

Researcher use AI to predict Alzheimer's disease progression

Author
Kyle Wiggers
Published
February 2, 2019

Researchers at Unlearn.AI, a startup that designs software tools for clinical research, think that artificial intelligence has a valuable role to play in personalizing diagnosis and treatment.

Enter your email address to download paper.

Click the link to begin download.
Oops! Something went wrong while submitting the form.
Blog

Digital Twins: A Tool for Risk Mitigation in the Era of COVID-19

Blog

CB Insights 2020 Digital Health 150: Unlearn.AI named in List of Most Innovative Digital Health Startups

Blog

Embracing Innovation to Move Forward

June 29, 2020
At Unlearn, our goal is to use the data available from historical trials, to generate new evidence to inform and advance research.
Read More
August 13, 2020
Unlearn is thrilled to be recognized as a contributing member of the international community of pioneers in health.
Read More
September 3, 2020
In what ways can we mitigate risk and apply innovative solutions to unstable trials in the wake of COVID-19?
Read More

Interested in a partnership?

Contact Us
© 2020 Unlearn.AI, Inc. All Rights Reserved